Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Generational Growth Opportunity for Canadian Cannabis

NetworkNewsWire Editorial Coverage:


News provided by

NetworkNewsWire

04 Oct, 2017, 12:30 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, October 4, 2017 /PRNewswire/ --

The medical cannabis business is booming in Canada, projected to ramp up and exceed $8 billion within seven years. The growth trajectory shows no signs of slowing yet pales in comparison to the global opportunity. A recent analysis by Eight Capital, a Toronto-based investment bank, targets the potential Canadian international medical cannabis market at a staggering $142 billion over the next 15 years (http://nnw.fm/aFP0h). Licensed producers in good standing are best positioned to reap immense rewards from this generational growth opportunity. Of these, ABcann Global Corp. (TSX-V: ABCN) (OTC: ABCCF) (ABcann Profile), among Canada's first licensed producers, is already considered one of its premiere growers. Others vying for position include OrganiGram Holdings, Inc. (OTC: OGRMF) (TSX-V: OGI), Supreme Pharmaceuticals, Inc. (OTC: SPRWF) (TSX-V: FIRE), Maricann Group, Inc. (OTC: MRRCF) (CSE: MARI) and iAnthus Capital Holdings, Inc. (OTC: ITHUF) (CSE: IAN).

With strict laws enacted in 2016, Health Canada now oversees the licensing process, monitoring and compliance of commercial medical cannabis producers. Licenses are difficult to acquire and frequent inspections hold producers to stringent standards. Health Canada now conducts thorough reviews of applications to ensure compliance with regulations and closely monitors licensed producers to ensure compliance with such strictures as personnel security measures, good production practices, packaging, shipping, record keeping, and importantly, import and export requirements. Global demand, especially in Germany, is growing at an 'insane' rate.

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) sees Germany as a gateway to vast European and global opportunities. "We're absolutely at the forefront," recent CEO Aaron Keay told Marijuana Business Daily. "We look at Europe as a significant part of our strategic plans for expansion, in addition to what we're doing domestically." Keay, now focused on global operations, confirmed that ABcann expects to acquire a distribution license and start exporting to Germany in the third quarter.

Meticulous specifications in the production of its pharmaceutical grade, plant-based medicines positions ABcann at the vanguard of Canadian global exporters of medical cannabis products. ABcann's modular approach to systems technology eliminates scale-up risk and enables ABcann to expand anywhere in the world and still maintain consistency and quality of product. Maintaining standards designed to exceed Canadian government requirements, ABcann Medicinals grows plants only in small batches to create controllable, consistent and predictable yields. The plants are nurtured in controlled environmental chambers to deliver repeatedly dependable results with each harvest. Chemical and pesticide free, ABcann produces medical cannabis that effectuates the same pharmaceutical response with each use. Such quality and consistency are prerequisites for importers of medicinal cannabis, especially in Germany that reimburses medical cannabis under its national health system.

In a testament to consistency, quality and immense global opportunity, Cannabis Wheaton, which invests in and supports a wide range of cannabis cultivation companies, announced in a June 2 press release a $30 million investment into ABcann for current operations and expansion to a 130,000-square-foot facility (http://nnw.fm/CHBi5). Cannabis Wheaton further committed to fully fund, with certain conditions, the construction of an additional 50,000 square feet of ABcann's Kimmett Facility. The 180,000 square feet of funded production capacity places ABcann among the top of all licensed producers. The $30 million investment is being made in two tranches each at C$2.25 per share. The pricing represents a significant premium to the current price of $0.78 US (about C$1.00) per share.

With a market capitalization around $82 million, ABcann presents great value for Cannabis Wheaton and should be on the radar of investors in this space. Other Canadian licensed producers carry much higher market valuations. Even at a C$2.25 per share valuation (about $180 million US market cap) ABcann still represents a compelling value in the industry with many licensed producers commanding valuations two to four times higher.

One such company carrying such a lofty market valuation is OrganiGram Holdings (OTCQB: OGRMF). With a market cap in excess of $233 million, OrganiGram will have over 220,000 square feet of medical cannabis production space at full build out. Even though its a federally licensed producer, OrganiGram was caught up in two Health Canada recalls of almost all its products sold in 2016 after residual levels of two banned pesticides, myclobutanil and bifenazate, were found and company's organic certification was suspended until compliance to requirements was demonstrated. Health Canada released a public recall of all products produced between February 1, 2016, and December 16, 2016, which included both dried marijuana and cannabis oil. OrganiGram took remedial measures to rectify the problems, is now back in business after losing a year's revenues and still carries a $230+ million valuation.

Supreme Pharmaceuticals (OTC: SPRWF) has a hefty market cap of around $250 million and is trying to become a leading supplier of affordable medical cannabis by applying commercial agriculture practices to medical cannabis production. Supreme Pharmaceuticals expects to produce 10,000 kilograms of cannabis in 2017, with an estimated value of $35 million. At the end of 2016, the company raised $55 million through a convertible debenture that pays investors 10% annually until maturity in January 2019, at which point the lenders can convert into equity at $1.30 per share which may prove quite dilutive.

Licensed in 2014 and with first sales in 2015, Maricann Group (OTCQB: MRRCF) is now expanding its cultivation, extraction, analytics and production facilities for growth into the adult-use cannabis market in Canada, and longer term, into mature and developing cannabis markets worldwide. In August the company reported Q2 sales declined by 27% from previous year levels and down 42% compared to Q1. Lacking environmental controls, Maricann attributed the shortfall to a March windstorm that allowed sand to enter its greenhouses and ultimately caused destruction of all impacted plants.

With a different approach and no licensed Canadian producers, iAnthus Capital Holdings (OTCQB: ITHUF), through its wholly owned subsidiary iAnthus Capital Management, LLC, offers investors diversified exposure to licensed cannabis cultivators, processors and dispensaries in the United States. iAnthus currently owns, operates or has partnered with marijuana license holders in Massachusetts, Vermont, Colorado and New Mexico. Founded by entrepreneurs with experience in investment banking, corporate finance, law and healthcare services, iAnthus provides a combination of capital and operating and management expertise for its companies. The diversification, while limiting downside in the space, severely constricts upside potential and is reflected in the paltry $36 million market valuation.

Canadian medical cannabis companies are uniquely primed and positioned to tap a generational global growth opportunity. Well-capitalized and largely free from competition, Canadian licensed producers are set to gain a first-mover advantage in new international markets as more and more countries legalize marijuana for medical use. Fortunes will be made as international medical cannabis markets balloon to $142+ billion over the next 15 years. To maximize profits in this space, investors should have direct exposure to licensed Canadian medical cannabis producers.

For more information on ABcann Global please visit: ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

http://www.NetworkNewsWire.com
212-418-1217 Office
Editor@NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with NNW or any company mentioned herein. The commentary, views and opinions expressed in this release by NNW are solely those of NNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW and FNM for any investment decisions by their readers or subscribers. NNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

NNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW and FNM undertake no obligation to update such statements.

NetworkNewsWire (NNW) & CannabisNewsWire (CNW) are proud to be affiliated partners of the Investor Based Brand Network (IBBN)

About IBBN

Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Please feel free to visit the Investor Based Brand Network (IBBN) http://www.investorbasedbrandnetwork.com


Media Contact:
FN Media Group, LLC
editor@financialnewsmedia.com
+1-954-345-0611

Modal title

Also from this source

AI-Powered Service Robots Redefine Hospitality as Industry Innovators Lead the Charge

AI-Powered Service Robots Redefine Hospitality as Industry Innovators Lead the Charge

Facing ongoing labor shortages and rising consumer demands, the hospitality and food service sectors are increasingly turning to artificial...

Unlocking the Future of Hospitality with AI-Powered Robotics, Invaluable Industry Expertise

Unlocking the Future of Hospitality with AI-Powered Robotics, Invaluable Industry Expertise

As labor shortages persist and consumer expectations rise, service robots powered by artificial intelligence (AI) are transforming the hospitality...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Investments Opinions

Investments Opinions

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.